Utilization of Reflex Testing for Direct Bilirubin in the Early Recognition of Biliary Atresia
|
|
- Dwain Jones
- 5 years ago
- Views:
Transcription
1 Clinical Chemistry 63: (2017) Evidence-Based Medicine and Test Utilization Utilization of Reflex Testing for Direct Bilirubin in the Early Recognition of Biliary Atresia Leo Lam, 1 Samarina Musaad, 2 Campbell Kyle, 1,2* and Stephen Mouat 3 BACKGROUND: Delayed diagnosis of biliary atresia is an important cause of pediatric end-stage liver failure and liver transplantation. We sought to determine whether direct bilirubin is underutilized by retrospectively reviewing patients with biliary atresia. Further, we aimed to determine the role of reflex testing for direct bilirubin in patients suspected for jaundice. METHODS: The time intervals between total bilirubin and direct bilirubin measurements were retrospectively reviewed in patients with biliary atresia. We also audited the results of two major laboratories that had implemented reflex testing for direct bilirubin. We evaluated the clinical impact and cost of reflex testing in infants with increased direct bilirubin ( 1.5 mg/dl; 25 mol/l). RESULTS: In patients with known biliary atresia, an isolated total bilirubin measurement preceded direct bilirubin measurement in 46% (40/87) of patients; with a median delay of 19 days (interquartile range 3 44 days). In the community setting, direct bilirubin had a higher clinical specificity for biliary atresia than in the hospital setting. Reporting direct bilirubin results in 1591 infants younger than 2 weeks of age in the community was associated with three admissions to the hospital, one of whom was diagnosed with biliary atresia. The cost for the two laboratories for direct-bilirubin testing was estimated at US$3200 (NZ$4600 ) for each newly diagnosed case of biliary atresia. CONCLUSIONS: We identified underutilization of direct bilirubin as a cause of delay in the recognition of biliary atresia and show that reflex testing for direct bilirubin in jaundiced infants is a cost-effective solution American Association for Clinical Chemistry Biliary atresia is characterized by progressive obstruction of the extrahepatic biliary tree in the newborn. Except for jaundice and acholic stools, infants appear well during the early stages of disease, which leads to delay in diagnosis. Biliary atresia is the most common cause of pediatric end-stage liver disease and is the leading indication for pediatric liver transplantation (1, 2). The standard of care is surgical drainage of the biliary tree (Kasai operation) followed by liver transplantation for those patients who progress to end-stage liver disease. With these treatments, the reported overall survival rates are 80% 90% at 4 years (3, 4); however, if untreated, this disease leads to end-stage liver failure and death by the age of 3 years (5, 6). The age at which Kasai operation is performed is a key prognostic factor and delayed presentation is the primary reason cited for not proceeding with surgical drainage (4, 7). A continuous association has been identified between the age at which Kasai operation is performed and long-term outcome (5). This association has also been made in countries that have actively reduced delays to Kasai operation using a stool color card screening program (8, 9). Taken together, earlier recognition of biliary atresia is a modifiable factor that improves clinical outcome. In this regard, multiple investigators have raised the importance of evaluating direct or conjugated bilirubin (DB/CB) 4 for biliary atresia in newborn screening (10 14). Studies to date suggest that a high clinical sensitivity and specificity could be achieved using DB/CB in infants from birth to 60 h of life (10, 11). Although further evaluation of newborn screening by DB/CB is still required, a potential problem is the collection of an additional plasma sample, which is currently not routinely performed for newborn screening in many countries. In this study, we sought to determine if automated requests initiated by clinical chemistry analyzers (reflex testing) for DB/CB in infants with increased total bilirubin could be a cost-effective practice in identifying those with biliary atresia. We achieved this by retrospectively reviewing a cohort of patients with biliary atresia to determine if there was a significant delay in requesting DB/ CB, after total bilirubin was tested. In addition, we de- 1 Department of Chemical Pathology, Labplus, Auckland City Hospital, Auckland, New Zealand; 2 Department of Biochemistry, Labtests, Auckland, New Zealand; 3 Department of Paediatric Gastroenterology, Starship Hospital, Auckland, New Zealand. * Address correspondence to this author at: LabPlus, Auckland City Hospital, Auckland, New Zealand. Fax ; CampbellK@adhb.govt.nz. Received October 24, 2016; accepted January 11, Previously published online at DOI: /clinchem American Association for Clinical Chemistry 4 Nonstandard abbreviations: DB/CB, direct bilirubin or conjugated bilirubin; ISO, International Organization for Standardization; CRAN, Comprehensive R Archive Network. 973
2 termined the cost and impact on hospital services using data from two laboratories that provide services for different populations: infants from the community and the hospital. Methods IDENTIFICATION OF PATIENTS Laboratory and clinical information from 3 separate cohorts were examined: patients with biliary atresia, patients with suspected jaundice in the community, and patients tested at a tertiary/quaternary referral hospital. A cohort of patients with biliary atresia was identified across New Zealand from a national database of all children with serious gastrohepatic disease. This database is managed by the Department of Gastroenterology at Starship Hospital, New Zealand. All patients with biliary atresia born in New Zealand from January 2003 to April 2016 were included. Biliary atresia was diagnosed by intraoperative cholangiogram or identification of an atretic extrahepatic biliary tree at the time of the Kasai operation. Where the Kasai operation was contraindicated, the diagnosis of biliary atresia was established in the presence of supportive histological findings and exclusion of other causes of liver failure such as Alagille syndrome, progressive familial intrahepatic cholestasis, and -1 antitrypsin deficiency. In total, 88 patients were identified and complete medical/laboratory records were obtained in 87 patients. One patient was excluded because laboratory records could not be obtained due to a change in laboratory provider and laboratory information system. Laboratory results and clinical information for each patient were requested from the patient s domicile laboratory and hospital. In total, 4030 consecutive results for total bilirubin were obtained from the community laboratory (Labtests Auckland) in infants younger than 6 months old, and 2608 consecutive results in infants between 2 weeks and 6 months old were obtained from the hospital laboratory (LabPlus, Auckland City Hospital) for the period between May 2014 and September 2015 inclusive. The community laboratory provides testing services for infants in Auckland in the community setting, while the hospital laboratory provides services for inpatients and some outpatients at the National Women s Hospital and the Starship Children s Hospital. These hospitals are tertiary/quaternary referral centers and national service providers for patients in the pediatric intensive care unit, liver transplant unit, heart transplant unit, metabolic services, and all levels of neonatal intensive care. For each patient with increased DB/CB direct bilirubin, electronic clinical records were retrieved to identify the cause. Where the same patient was tested at both laboratories, the earliest result was used. The cause of increased direct bilirubin was categorized for each patient (Table 1). Table 1. Classification of patients with increased direct bilirubin. a Category New biliary atresia Gastrohepatic PICU/NICU b Hypothyroidism Unexplained Antibody-mediated hemolysis New cases of biliary atresia. All patients with a primary or secondary gastrointestinal or hepatic cause for increased direct bilirubin. These causes include biliary atresia (existing cases), intestinal failure associated liver disease, neonatal hepatitis, giant cell hepatitis, paucity of biliary ducts or Alagille syndrome, liver failure from type 1 tyrosinemia, or of uncertain etiology and intrahepatic hemangioma. Any patients admitted to an intensive care unit or are critically ill. These patients have multifactorial causes for jaundice. Where no other causes could be identified except for hypothyroidism. All patients investigated for jaundice for which there was no cause identified or where no further followup was required. All patients with positive direct antiglobulin test where an alternative cause could not be found. a Patients with increased bilirubin were categorized based on review of their clinical documentation. b PICU/NICU, pediatric intensive care unit/neonatal intensive care unit. The study received institutional approval from the Auckland District Health Board (A 6619) and was exempted from further review by the New Zealand Health and Disability Ethics Committees. LABORATORY METHODS AND CRITERIA FOR REFLEX TESTING In the community laboratory, reflex testing for direct bilirubin was performed on all children younger than 6 months of age. The same was performed in the hospital laboratory for children between 2 weeks and 6 months old with a total bilirubin 3.5 mg/dl ( 60 mol/l). At both laboratories, direct bilirubin was performed using the Roche method for direct bilirubin (generation 2) on a Cobas c501 analyzer. Total bilirubin was measured using the Roche method for total bilirubin (generation 3) on a Cobas c501 analyzer at the community laboratory and 974 Clinical Chemistry 63:5 (2017)
3 Reflex Testing for Direct Bilirubin Table 2. Timing of bilirubin tests and Kasai operations in patients with biliary atresia. a Simultaneous (n = 47) Delayed (n = 40) P value Age at first total bilirubin, days 49 (33 64) 6 (2 23) < b Age at first DB/CB, days 46 (34 63) 44 (15 42) 0.17 Age at Kasai, days 63 (50 70) 60 (43 75) 0.49 Delay between DB/CB and Kasai, days 13 (9 19) 19 (13 27) a Patients with biliary atresia were separated into patients who had DB/CB performed at the same time (Simultaneous) and those that did not (Delayed). Delays are recorded in days with the interquartile range shown in parentheses. Two patients who did not receive Kasai operation were excluded for Kasai related measurements. b Bonferroni adjusted P value of < indicated a significant difference. the same assay on a Cobas c701 analyzer at the hospital laboratory. Samples tested for direct bilirubin were identified as hemolyzed using an H-index cutoff of 25, corresponding to an approximate plasma hemoglobin concentration of 25 mg/dl (15.5 mol/l) at both laboratories. Both laboratories were accredited by International Accreditation New Zealand under the International Organization for Standardization (ISO)15189 standard for laboratories and maintain excellent performance in the Royal College of Pathologists of Australasia external Quality Assurance Program for these analytes. STATISTICS AND CALCULATIONS Comparison of the timing of tests and the Kasai operation was performed using the Mann Whitney U-test. Calculation of clinical specificity was performed by identifying results from patients with a new diagnosis of biliary atresia as positive cases and all remaining cases that fulfilled the reflex criteria for each laboratory as negative. A distribution of specificities was calculated by bootstrap resampling with 2000 repetitions using the proc package from the Comprehensive R Archive Network (CRAN) (15). The clinical specificity and its confidence interval were taken from the median, 2.5th and 97.5th percentile of this distribution. In patients with more than one direct bilirubin result, we took the first direct bilirubin that fulfilled the criteria of reflex testing for each laboratory. For both laboratories, the estimated cost for each direct bilirubin test was US$0.70 (NZ$1) factoring in reagent cost, labor, and fixed overheads. The overall cost per new diagnosis was calculated by following formula: (cost per direct bilirubin test) (number of direct bilirubin tests performed)/(number of new biliary atresia identified by reflex). Results UNDERUTILIZATION AND DELAY IN TESTING OF DIRECT BILIRUBIN Examining the national database for biliary atresia, of 87 patients identified with biliary atresia, 47 had testing for both DB/CB and total bilirubin on their initial sample while 40 patients did not have testing done. The only significant difference between the 2 groups was the age at which total bilirubin was tested (Table 2). Interestingly, the age at which the Kasai operation was performed did not reach statistical significance between the two groups. For patients who did not have simultaneous testing for DB/CB, 26 patients were younger than 14 days of age at the time of their first total bilirubin test. The age at which Kasai operation was performed correlated with the age of the first DB/CB test (R 0.85, P ). There was a weak association with age at the time of first total bilirubin test (R 0.49, P ). In patients where initial simultaneous testing was not performed, the median time before DB/CB testing was 19 days (interquartile range 3 44, Fig. 1). These findings suggested that children with biliary atresia often had total bilirubin tested at an early age. Thus, the opportunity to recognize this disease was often missed due to the underutilization of DB/CB. POTENTIAL BENEFIT OF REFLEX TESTING Examining the two laboratories that had recently implemented reflex testing, hemolysis and insufficient sample volume were identified as common causes for the inability to test for DB/CB. These causes affected 18% of samples fulfilling the reflex criteria in the community and 29% in the hospital setting (Fig. 2). In examining the first DB/CB result for each patient that fulfilled the reflex criteria, the median age at the time of first total bilirubin test was found to be 8 days (interquartile range 4 24) in the community and 27 days (interquartile range 20 40) in the hospital. Using a clinical decision-making threshold of 1.5 mg/dl (25 mol/l) for DB/CB, the clinical specificity was 99.1% (95% CI 98.7% 99.5%) in the community and 69% (61% 77%) at the hospital. Table 1 in the Data Supplement that accompanies the online version of this article at 63/issue 5 shows a contingency table for patients who fulfilled the criteria for reflex testing. At every cutpoint examined, the clinical specificity remained higher Clinical Chemistry 63:5 (2017) 975
4 in the community setting after accounting for the difference in age (see online Supplemental Fig. 1). Since we were unable to determine from the laboratory information systems which of the samples had undergone reflex testing, request forms for patients with increased DB/CB were examined to determine whether direct bilirubin had been requested by clinicians. In taking the first increased direct bilirubin result for each patient, reflex testing identified 29% (10/34) of community patients and 59% (26/44) of hospital patients with increased DB/CB. These findings indicated that reflex testing identified a large proportion of patients with increased DB/CB who would have been missed by relying on clinical requesting. Fig. 1. Delay in obtaining direct or conjugated bilirubin. The delay between obtaining total bilirubin and the first DB/CB in infants with biliary atresia that did not have simultaneous testing. No significant difference could be observed between those younger or older than 14 days of age (P = 0.12). CLINICAL IMPACT AND COST OF REFLEX TESTING The most common association with increased DB/CB in patients in the community was antibody-mediated hemolysis, although most remained unexplained (Table 3); these patients had a relatively low proportion of DB/CB compared to their total bilirubin (Fig. 3). In contrast, gastrohepatic disorders were the most common cause for increased DB/CB in the hospital. In keeping with local and international guidelines, all patients in the community older than two weeks of age with increased DB/CB, except one, were followed up at the hospital. In contrast, DB/CB testing in 1591 infants younger than 2 weeks resulted in 21 patients with increased DB/CD and three admissions to hospital. In two of these, no cause for jaundice could be identified, while a new diagnosis of biliary atresia was made in one. For the remaining 18 infants investigated in the community, 16 had follow-up, including repeat total and direct bilirubin, which was considered reassuring; however, none of them progressed to imaging as a final rule-out investiga- Fig. 2. Requests for total bilirubin from the community and hospital laboratory. The number of samples and individuals less than 2 weeks of age is indicated in parentheses. A direct bilirubin of 1.5 mg/dl corresponds to 25 μmol/l. 976 Clinical Chemistry 63:5 (2017)
5 Reflex Testing for Direct Bilirubin Table 3. Number of patients with increased direct bilirubin detected by reflex testing. a Overall Community N Age, days 14 days >14 days Hospital, >14 days New biliary atresia 4 37 (14 65) Gastrohepatic (24 83) PICU/NICU b (16 62) Hypothyroidism 2 64 (63 66) Antibody-mediated hemolysis 7 4 ( ) Unexplained 17 5 (4 20) Total (6 61) a Where a patient had more than 1 test from both laboratories, only the first increased direct bilirubin was accounted for. The median age and interquartile ranges of patients are provided. b Three neonates were tested for direct bilirubin in the community laboratory within 5 days of discharge from neonatal intensive care unit (NICU). These neonates either did not fulfil reflex criteria of the hospital laboratory or were treated at a different hospital. PICU/NICU, pediatric intensive care unit/nicu. tion. These findings suggested that, in patients under 2 weeks of age, reflex testing for DB/CB was useful in identifying patients with biliary atresia and did not lead to a substantial increase in the number of hospital presentations. During the study period, a total of 8 patients were identified as having new or preexisting biliary atresia, of which four had a new diagnosis. One of the four was identified as having increased direct bilirubin via reflex testing (as previously described); in the remaining 3 patients, direct bilirubin was requested by a clinician. Using each laboratory s criteria for reflex testing on all samples received, the cost of DB/CB tests combined for both community and hospital laboratories over a period of 17 months was estimated at US$3200 (NZ$4600 ) for each new case of biliary atresia identified. Discussion In this study, we investigated the value of testing for DB/CB in addition to total bilirubin in infants investi- Fig. 3. Distribution of total, direct, and percentage direct bilirubin in patients with increased direct bilirubin detected by reflex testing. Patients with increased direct bilirubin were categorized according to their underlying medical illness. The median, interquartile range, and absolute range are shown for each category. PICU/NICU, pediatric intensive care unit/neonatal intensive care unit; AMH, antibody-mediated hemolysis. Clinical Chemistry 63:5 (2017) 977
6 gated for jaundice. We examined three separate datasets: the national database for biliary atresia and datasets from a community laboratory and a hospital laboratory that had implemented reflex testing. Although previous studies have indicated that a high clinical sensitivity and specificity of DB/CB during the first days of life can be used to identify biliary atresia (10, 11, 16), the implementation of a national screening program for biliary atresia by testing for DB/CB has not been fully evaluated (13). Reflex testing therefore represents an opportunity to detect patients with biliary atresia at an earlier age. We found that the timing of DB/CB testing was associated with the age at which the Kasai operation was performed. However, this test was often requested later than total bilirubin. This is supported by our retrospective audit of patients with increased DB/CB, where a large proportion of requesters did not indicate DB/CB on their request forms. Taken together, our results indicate delays in obtaining DB/CB as an important cause of delay in the diagnosis of biliary atresia. Reflex testing is an operator independent mechanism that identifies all patients with potentially increased direct bilirubin. This test has high clinical specificity in the community, while in the hospital clinical specificity is lower because of associated morbidities, e.g., critical illness and gastrohepatic pathologies. The consequence of delayed diagnosis and management of biliary atresia is a reduction in native liver survival or overall survival (5). At our center, a case of pediatric liver transplant and its associated cost is estimated at US$ (NZ$250000) with an ongoing annual cost of US$14000 (NZ$20000) per year. In comparison, the estimated cost of US$3200 (NZ$4600) per newly diagnosed case of biliary atresia supports reflex testing for DB/CB as highly cost-effective. Furthermore, testing DB/CB on all patients in the community in the past 17 months did not result in a substantial increase in the number of patients unnecessarily presenting to the hospital. These findings suggest that reflex testing is a costeffective intervention with minimal interruption to hospital service delivery. The strengths of our study include the availability of a database containing all patients in New Zealand with biliary atresia over a 13-year period, which allowed us to identify baseline practices of all laboratories in the country, as well as all patients with biliary atresia who had reflex testing. Because the same DB/CB assay was used in the community and hospital laboratories, a fair comparison of results could be made. In contrast to population screening, reflex testing has the advantage of identifying cases among children who present to laboratories for blood tests and therefore are more likely to be clinically jaundiced. DB/CB testing in this population has a higher pretest probability for biliary atresia. In our study, 4 of 2312 patients were identified with newly diagnosed biliary atresia, a considerably higher rate than the typical rate of 1: 8000 in New Zealand derived from our national database and the 1: : reported in some European countries (3). The higher pretest probability results in a lower cost of performing this test for each new diagnosis made. However, it should be noted that reflex testing alone does not improve the time to first presentation to the healthcare system and is therefore not a complete substitute for a national screening program. Although current guidelines recommend the testing of DB/CB in all infants suspected of jaundice who are older than 2 weeks (17, 18), our findings indicate nonadherence to this recommendation as another cause of delayed management in children with biliary atresia. One limitation of reflex testing is providing results that clinicians may not anticipate, which may lead to inadequate follow-up or management. In this regard, the hospital laboratory has adopted automated commenting advising clinical staff to consider the causes of increased DB/CB and to monitor for acholic stools. In addition, the community laboratory regards all DB/CB results 1.5 mg/dl ( 25 mol/l) in infants as critical, requiring communication to the clinician by telephone. However, we were unable to determine if all patients with increased direct bilirubin were followed up appropriately. The limitations of our study include the relatively small number of newly diagnosed biliary atresia patients, which limited the ability to determine the diagnostic utility of DB/CB testing. In addition, current DB/CB measurements across different analyzers are not harmonized (19, 20), and there is a lack of consensus on the appropriate clinical decision making threshold. The use of reflex DB/CB testing in hospital patients 14 days of age was not evaluated in our study because the hospital laboratory had not implemented reflex testing. Finally, the limited number of newly diagnosed biliary atresia patients did not allow the measurement of clinical outcomes. Our results indicate that delays in DB/CB testing occur in a large proportion of children with biliary atresia and support reflex testing as a cost-effective solution to overcome this problem. Laboratories should consider differences between patients in the community and hospital when implementing reflex testing and consider increased direct bilirubin as a critical test in infants from the community. Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article. 978 Clinical Chemistry 63:5 (2017)
7 Reflex Testing for Direct Bilirubin Authors Disclosures or Potential Conflicts of Interest: Upon manuscript submission, all authors completed the author disclosure form. Disclosures and/or potential conflicts of interest: Employment or Leadership: None declared. Consultant or Advisory Role: C.V. Kyle, Labtests Auckland. Stock Ownership: None declared. Honoraria: None declared. Research Funding: None declared. Expert Testimony: None declared. References Patents: None declared. Role of Sponsor: No sponsor was declared. Acknowledgments: We would like to thank members of the Auckland Regional Quality Assurance Group for their support and implementation of reflex testing for direct/conjugated bilirubin. We would like to thank Associate Professor James Davidson (former head of Chemical Pathology, LabPlus) for his assistance with the proofreading of the manuscript. We wish him all the best in his retirement. 1. Wilde J, Chin S, Johnston P, McCall J, Munn S, Nixon C, et al. Paediatric liver transplantation in New Zealand: the first 5 years. N Z Med J 2007;120:U Sokol RJ, Mack C, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: Current concepts. J Pediatr Gastroenterol Nutr 2003;37: Chardot C. Biliary atresia. Orphanet J Rare Dis 2006;1: Schreiber RA, Barker CC, Roberts EA, Martin SR, Alvarez F, Smith L, et al. Biliary atresia: the Canadian experience. J Pediatr 2007;151:659 65, 665.e1. 5. Serinet MO, Wildhaber BE, Broue P, Lachaux A, Sarles J, Jacquemin E, et al. Impact of age at Kasai operation on its results in late childhood and adolescence: a rational basis for biliary atresia screening. Pediatrics 2009;123: Bates MD, Bucuvalas JC, Alonso MH, Ryckman FC. Biliary atresia: pathogenesis and treatment. Semin Liver Dis 1998;18: Superina R, Magee JC, Brandt ML, Healey PJ, Tiao G, Ryckman F, et al. The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Ann Surg 2011; 254: Gu YH, Yokoyama K, Mizuta K, Tsuchioka T, Kudo T, Sasaki H, et al. Stool color card screening for early detection of biliary atresia and long-term native liver survival: a 19-year cohort study in Japan. J Pediatr 2015;166: e1. 9. Lien TH, Chang MH, Wu JF, Chen HL, Lee HC, Chen AC, et al. Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology 2011;53: Harpavat S, Finegold MJ, Karpen SJ. Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatrics 2011;128:e Harpavat S, Ramraj R, Finegold MJ, Brandt ML, Hertel PM, Fallon SC, et al. Newborn direct/conjugated bilirubin measurements as a potential screen for biliary atresia. J Pediatr Gastroenterol Nutr 2015;62: Wang KS, Section on Surgery, Committee on Fetus and Newborn, Childhood Liver Disease Research Network. Newborn screening for biliary atresia. Pediatrics 2015; 136:e Sokol RJ. Newborn screening for biliary atresia: bilirubin or bust? J Pediatr Gastroenterol Nutr 2016;63: Sokol RJ, Shepherd RW, Superina R, Bezerra JA, Robuck P, Hoofnagle JH. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop. Hepatology 2007;46: Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. proc: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12: Powell JE, Keffler S, Kelly DA, Green A. Population screening for neonatal liver disease: potential for a community-based programme. J Med Screen 2003; 10: MoyerV, FreeseDK, WhitingtonPF, OlsonAD, BrewerF, Colletti RB, Heyman MB. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004;39: Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, andnutritionandtheeuropeansocietyfor Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2017;64: Greene DN, Liang J, Holmes DT, Resch A, Lorey TS. Neonatal total bilirubin measurements: still room for harmonization. Clin Biochem 2014;47: Harpavat S, Devaraj S, Finegold MJ. An infant with persistent jaundice and a normal newborn direct bilirubin measurement. Clin Chem 2015;61: Clinical Chemistry 63:5 (2017) 979
Patients With Biliary Atresia Have Elevated Direct/ Conjugated Bilirubin Levels Shortly After Birth
Patients With Biliary Atresia Have Elevated Direct/ Conjugated Bilirubin Levels Shortly After Birth WHAT S KNOWN ON THIS SUBJECT: Infants with biliary atresia (BA) have better outcomes if detected and
More informationCystic Biliary Atresia: Why Is It Important to Distinguish this from Congenital Choledochal Cyst?
Bahrain Medical Bulletin, Vol. 36, No. 2, June 2014 Cystic Biliary Atresia: Why Is It Important to Distinguish this from Congenital Choledochal Cyst? Hussein Ahmed Mohammed Hamdy, MRCSEd, FEBPS* Hind Mustafa
More informationBiliary atresia (BA) is the most frequent cause
A pilot study using stool color card in Beijing Modified stool color card with digital images was efficient and feasible for early detection of biliary atresia a pilot study in Beijing, China Yuan-Yuan
More informationBiliary atresia (BA) is an inflammatory, progressive
Effects of the Infant Stool Color Card Screening Program on 5-Year Outcome of Biliary Atresia in Taiwan Tien-Hau Lien, 1 Mei-Hwei Chang, 1 Jia-Feng Wu, 1 Huey-Ling Chen, 1 Hung-Chang Lee, 2 An-Chyi Chen,
More informationNeonatal Cholestasis. What is Cholestasis? Congenital and Pediatric liver diseases 4/26/18
Congenital and Pediatric liver diseases Nitika Gupta, M.D. Personal/Professional Financial Relationships with Industry in the past year External Industry Relationships * Equity, stock, or options in biomedical
More informationInsulin-like Growth Factor-1 (IGF-1) in Children with Postoperative Biliary Atresia: A Cross-Sectional Study
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY (2008) 26: 53-57 53 Insulin-like Growth Factor-1 (IGF-1) in Children with Postoperative Biliary Atresia: A Cross-Sectional Study Nopaorn Phavichitr 1, Apiradee
More informationCan Universal Screening for rare conditions ever be cost-effective? The case of Newborn Screening for Biliary Atresia
Can Universal Screening for rare conditions ever be cost-effective? The case of Newborn Screening for Biliary Atresia Lisa Masucci 1, Stirling Bryan 1, Janusz A. Kaczorowski 3, Jean-Paul Collet 2, Richard
More informationBiliary Atresia. Greg Tiao, MD. 3 rd Annual Pediatric Surgery Update Course GlobalCastMD
Biliary Atresia Greg Tiao, MD GlobalCastMD 3 rd Annual Pediatric Surgery Update Course 2015 Case Pediatrician calls you about a 60 day old full term male who is otherwise healthy but is noted to have persistent
More informationProlonged Neonatal Jaundice
Prolonged Neonatal Jaundice Ahmed Laving KPA Annual Scientific Conference 2018 Prolonged Jaundice? >6 months >3 months >2 weeks >4 weeks Prolonged Jaundice? >6 months >3 months >2 weeks >4 weeks Case Presentation
More informationFree University of Brussels, *Department of Pediatrics, Universitair Ziekenhuis Brussel, Brussels, Belgium
pissn: 22348646 eissn: 22348840 http://dx.doi.org/10.5223/pghn.2014.17.3.191 Pediatr Gastroenterol Hepatol Nutr 2014 September 17(3):191195 Case Report PGHN Hemorrhagic Diathesis as the Presenting Symptom
More informationBILIARY ATRESIA. What is biliary atresia?
The Childhood Liver Disease Research Network strives to provide information and support to individuals and families affected by liver disease through its many research programs. BILIARY ATRESIA What is
More informationInfants with extrahepatic biliary atresia: Effect of follow-up on the survival rate at Ege University Medical School transplantation center
Pediatric Gastroenterology Infants with extrahepatic biliary atresia: Effect of follow-up on the survival rate at Ege University Medical School transplantation center Miray Karakoyun 1, Maşallah Baran
More informationSzu-Ying Chen 1,2, Chieh-Chung Lin 1, Yu-Tse Tsan 3,4,5, Wei-Cheng Chan 3, Jiaan-Der Wang 1,6*, Yi-Jung Chou 7 and Ching-Heng Lin 8
Chen et al. BMC Pediatrics (2018) 18:119 https://doi.org/10.1186/s12887-018-1074-2 RESEARCH ARTICLE Open Access Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation
More informationBiliary Atresia. Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s
Biliary Atresia Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s Biliary Atresia Incidence: 1/8,000-15,000 live births Girls > boys 1.5:1 The most common cause
More informationCurrent Management of Biliary Atresia. Janeen Jordan, MD PGY5 Surgery Grand Rounds November 19, 2007
Current Management of Biliary Atresia Janeen Jordan, MD PGY5 Surgery Grand Rounds November 19, 2007 Overview Etiology and diagnosis Work-up and management History of Kasai Portoenterostomy Studies Advances
More information2009 The Authors. Journal compilation 2009 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
Outcome of biliary atresia in Malaysia: A single-centre study 1. Way-Seah Lee 1,*, 2. Pei-Fan Chai 1, 3. Kean-Seng Lim 1, 4. Li-Han Lim 1, 5. Lai-Meng Looi 2, 6. Trndivanam Muthurangam Ramanujam 3 Article
More informationJaundice Protocol. Early identification and referral of liver disease in infants. fighting childhood liver disease. fighting childhood liver disease
fighting childhood liver disease Jaundice Protocol Early identification and referral of liver disease in infants fighting childhood liver disease 36 Great Charles Street Birmingham B3 3JY Telephone: 0121
More informationA review of histological parameters and CMV serology in Biliary atresia, and its relationship to long-term outcomes
A review of histological parameters and CMV serology in Biliary atresia, and its relationship to long-term outcomes DR A. WITHERS, DR A. GRIEVE DEPARTMENT OF PAEDIATRIC SURGERY UNIVERSITY OF THE WITWATERSRAND
More informationAspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis
The Turkish Journal of Pediatrics 2015; 57: 492-497 Original Aspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis Aysel Ünlüsoy-Aksu 1,
More informationUltrasonographic Triangular Cord Sign and Gallbladder Abnormality in Diagnosis of Biliary Atresia
Iranian Journal of Neonatology 14 Ultrasonographic Triangular Cord Sign and Gallbladder Abnormality in Diagnosis of Biliary Atresia Seyed Ali Jafari*, MD,1 Mehrzad Mehdizadeh, MD,2 Fatemeh Farahmand, MD,
More informationPARENTERAL NUTRITION- ASSOCIATED LIVER DISEASE IN CHILDREN
PARENTERAL NUTRITION- ASSOCIATED LIVER DISEASE IN CHILDREN Praveen Goday MBBS CNSC Associate Professor Pediatric Gastroenterology Medical College of Wisconsin Milwaukee, WI Parenteral Nutrition-Associated
More informationApproach to a case of Neonatal Cholestasis
Approach to a case of Neonatal Cholestasis Ira Shah (Co-Incharge, Consultant Pediatrician, Pediatric Liver Clinic) Gunjan Narkhede (Resident in Pediatric Liver Clinic) Pediatric Hepatobiliary Clinic, B.J.Wadia
More informationResearch Article Mortality of Biliary Atresia in Children Not Undergoing Liver Transplantation in Egypt (Single Institutional Study)
Cronicon OPEN ACCESS Yasser K Rashed 1 *, Behairy E Behairy 1, Magdy A Saber 1, Taha E Yassein 2 and Eman Z Soliman 1 1 Department of Pediatric Hepatology, National Liver Institute, Menoufiya University,
More informationPREDICTING RENAL DYSFUNCTION FOLLOWING PAEDIATRIC LIVER TRANSPLANTATION
PREDICTING RENAL DYSFUNCTION FOLLOWING PAEDIATRIC LIVER TRANSPLANTATION Starship Children s Hospital, Auckland, New Zealand January-February 2014 Michael Webb & William Jenner m.webb@ucl.ac.uk w.jenner@ucl.ac.uk
More informationComparing Transcutaneous to Serum Bilirubin after Phototherapy in the Outpatient Setting
Comparing Transcutaneous to Serum Bilirubin after Phototherapy in the Outpatient Setting Item Type Thesis Authors Makarova, Natasha Publisher The University of Arizona. Rights Copyright is held by the
More informationAetiology and outcome of neonatal cholestasis in Malaysia
Original Article Singapore Med J 2010, 51(5) 434 Aetiology and outcome of neonatal cholestasis in Malaysia Lee W S, Chai P F, Boey C M, Looi L M Department of Paediatrics, University of Malaya Medical
More informationOriginal Article Hepatobiliary Scintigraphy & Bilirubin Profile Pak Armed Forces Med J 2018; 68 (4):
Open Access Original Article Hepatobiliary Scintigraphy & Bilirubin Profile Pak Armed Forces Med J 2018; 68 (4): 706-11 ROLE OF HEPATOBILIARY SCINTIGRAPHY & BILIRUBIN PROFILE IN EARLY DIAGNOSIS OF BILIARY
More informationOptimal Distribution and Utilization of Donated Human Breast Milk: A Novel Approach
653738JHLXXX10.1177/0890334416653738Journal of Human LactationSimpson et al research-article2016 Original Research: Brief Report Optimal Distribution and Utilization of Donated Human Breast Milk: A Novel
More informationUSE OF A CONDITIONAL QUANTILES METHOD TO PREDICT FUTURE HEALTH OUTCOMES BASED ON THE TRAJECTORY OF PEDIATRIC END-STAGE LIVER DISEASE (PELD) SCORES
USE OF A CONDITIONAL QUANTILES METHOD TO PREDICT FUTURE HEALTH OUTCOMES BASED ON THE TRAJECTORY OF PEDIATRIC END-STAGE LIVER DISEASE (PELD) SCORES by YuZhou Liu B.S in Actuarial Mathematics, University
More informationNEONATAL CHOLESTASIS AND BILIARY ATRESIA: PERSPECTIVE FROM MALAYSIA
NEONATAL CHOLESTASIS AND BILIARY ATRESIA: PERSPECTIVE FROM MALAYSIA Lee WS Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. ABSTRACT: The liver is an important
More informationOutcomes of Liver Transplant for Biliary Atresia: A Ten Year Single Centre Experience
Outcomes of Liver Transplant for Biliary Atresia: A Ten Year Single Centre Experience Dr Yentl van Heerden; Dr Andrew Grieve, Professor Jerome Loveland For Paediatric Hepatobiliary and Liver Transplant
More informationProfound hypocalcemia in an infant with jaundice Batul Kaj, MD; Shaida Nasiri, MD; Harpreet Pall, MD*
Open Journal of Clinical & Medical Case Reports Profound hypocalcemia in an infant with jaundice Batul Kaj, MD; Shaida Nasiri, MD; Harpreet Pall, MD* *Harpreet Pall, MD Volume 3 (2017) Issue 20 ISSN 2379-1039
More informationPresentation and mortality of primary biliary cirrhosis in older patients
Age and Ageing 2000; 29: 305 309 Presentation and mortality of primary biliary cirrhosis in older patients JULIA L. NEWTON 1,DAVID E. JONES 2,JANE V. METCALF 2,JAY B. PARK 2,ALISTAIR D. BURT 2, MARGARET
More informationOutcome of liver disease in children with Alagille syndrome: a study of 163 patients
Gut 2001;49:431 435 431 Service d Hépatologie Pédiatrique, Hôpital de Bicêtre, 94275 Le Kremlin Bicêtre Cedex, France P Lykavieris M Hadchouel O Bernard Unité INSERM 347, 94276 Le Kremlin Bicêtre Cedex,
More informationHome Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary Atresia
Home Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary Atresia Hye Kyung Chang, Jung-Tak Oh, Seung Hoon Choi, Seok Joo Han Division of Pediatric Surgery, Department of Surgery, Yonsei
More informationTransition of Care From Pediatric to Adult GI
Transition of Care From Pediatric to Adult GI Michele Cho-Dorado MD Pediatric Gastroenterology Combined Division of Pediatric Gastroenterology, Hepatology and Nutrition Advocate Children s Hospital Children
More informationBiliary Atresia. Who is at risk for biliary atresia?
Biliary Atresia Biliary atresia is a life-threatening condition in infants in which the bile ducts inside or outside the liver do not have normal openings. Bile ducts in the liver, also called hepatic
More informationBackground OVER 30 ISSUES IDENTIFIED! Key opportunities. What we ve done. October 31, 2012
Background Hyperbilirubinemia: Developed by CMNRP s Jaundice Working Group Strategic planning meeting of CMNRP and its committees Multiple tables identified jaundice as a problem/priority Opportunity to
More informationNutritional Issues in Cholestatic Disease
THE HOSPITAL FOR SICK CHILDREN Nutritional Issues in Cholestatic Disease NASPGHAN-CPNP Joint Session Binita M. Kamath, MBBChir MRCP MTR Associate Professor Division of Gastroenterology, Hepatology and
More informationInformation for patients (and their families) waiting for liver transplantation
Information for patients (and their families) waiting for liver transplantation Waiting list? What is liver transplant? Postoperative conditions? Ver.: 5/2017 1 What is a liver transplant? Liver transplantation
More informationOHTAC Recommendation
OHTAC Recommendation Clinical Utility of Serologic Testing for Celiac Disease in Asymptomatic Patients Presented to the Ontario Health Technology Advisory Committee in May and June 2011 July 2011 Background
More informationNeonatal Cholestasis-Approach and Management
Medical Science Neonatal Cholestasis-Approach and Management KEYWORDS Cholestatic jaundice, Neonate, Practice guidelines Dr. Siddhartha Nandi Post graduate, Department of Paediatrics, Jawaharlal Nehru
More informationPaediatric Liver Transplant Programme Wits Donald Gordon Medical Centre
Paediatric Liver Transplant Programme Wits Donald Gordon Medical Centre J Loveland, J Botha, R Britz, B Strobele, S Rambarran, A Terblanche, C Kock, P Walabh, M Beretta, M Duncan et al 1817 reveal the
More information1 University of Kansas School of Medicine-Wichita, Department of Pediatrics 2 Wesley Medical Center, Department of Neonatology
Impact of on Very Low Birth Weight Infants Siddharthan Sivamurthy, M.D. 1, Carolyn R. Ahlers-Schmidt, Ph.D. 1, Katherine S. Williams, M.Ed. 1, Jared Shaw 2, Paula Delmore, M.S.N. 2, Barry T. Bloom, M.D.
More information11/8/12. KERNICTERUS: The reason we have to care about bilirubin. MANAGING JAUNDICE IN THE BREASTFEEDING INFANT AKA: Lack of Breastfeeding Jaundice
MANAGING JAUNDICE IN THE BREASTFEEDING INFANT AKA: Lack of Breastfeeding Jaundice November 16, 2012 Orange County Lawrence M. Gartner, M.D. University of Chicago and Valley Center, California KERNICTERUS:
More informationDonor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation
8 Original Article Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation Neema Kaseje 1 Samuel Lüthold 2 Gilles Mentha 3 Christian Toso 3 Dominique Belli 2 Valérie McLin 2 Barbara
More informationAmmonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality
More informationBiliary atresia (BA) is the most common lifethreatening. Universal Screening for Biliary Atresia Using an Infant Stool Color Card in Taiwan
AUTOIMMUNE, CHOLESTATIC AND BILIARY DISEASE Universal Screening for Biliary Atresia Using an Infant Stool Color Card in Taiwan Cheng-Hui Hsiao, 1 Mei-Hwei Chang, 2 Huey-Ling Chen, 2 Hung-Chang Lee, 3,4
More informationJMSCR Vol 05 Issue 04 Page April 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i4.99 Original Articles Umbilical Cord Bilirubin-an
More informationDescription of the evidence collection method. (1). Each recommendation was discussed by the committee and a consensus
Special Article Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Sandra Regina Loggetto 1
More informationCase report Idiopathic neonatal hepatitis or extrahepatic biliary atresia? The role of liver biopsy
Case report Idiopathic neonatal hepatitis or extrahepatic biliary atresia? The role of liver biopsy Abdelmoneim EM Kheir (1), Wisal MA Ahmed (2), Israa Gaber (2), Sara MA Gafer (2), Badreldin M Yousif
More informationLiver Space. A facebook health application to strengthen online communities
Liver Space A facebook health application to strengthen online communities Douglas Mogul, MD MPH Assistant Professor of Pediatrics Johns Hopkins University May, 2016 Importance of Early Diagnosis in BA
More informationWhat Is the Real Gain After Liver Transplantation?
LIVER TRANSPLANTATION 15:S1-S5, 9 AASLD/ILTS SYLLABUS What Is the Real Gain After Liver Transplantation? James Neuberger Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom;
More informationUnique Aspects of the Neonatal Immune System Provide Clues to the Pathogenesis of Biliary Atresia. Disclosures. Objectives
Unique Aspects of the Neonatal Immune System Provide Clues to the Pathogenesis of Biliary Atresia Cara L. Mack, MD Associate Professor of Pediatrics Pediatric GI, Hepatology & Nutrition Children s Hospital
More informationScreening for Phenylketonuria: A Literature Update for the U.S. Preventive Services Task Force
Screening for Phenylketonuria: A Literature Update for the U.S. Preventive Services Task Force Prepared by: Iris Mabry-Hernandez, MD, MPH Tracy Wolff, MD, MPH Kathy Green, MD, MPH Corresponding Author:
More informationA STUDY ON LONGTERM OUTCOMES OF POSTERIOR URETHRAL VALVES
3 Original article A STUDY ON LONGTERM OUTCOMES OF POSTERIOR URETHRAL VALVES Dr. Urvish R. Parikh [1], Dr Sudhir B. Chandana [], Dr Vinay M. Rohra [3],, Dr Jay B. Pandya [5], Dr Ankit B. Kothari [4] Assistant
More informationDEKAs in Cholestatic Liver Disease
DEKAs in Cholestatic Liver Disease All-in-one Multivitamin Food for Special Medical Purposes with Enhanced Absorption for the Dietary Management of Cholestatic Liver Disease Roberto Jongejan, MD, PhD Gus
More informationSHORT COMMUNICATION. G. Joshy & P. Dunn & M. Fisher & R. Lawrenson
Diabetologia (2009) 52:1474 1478 DOI 10.1007/s00125-009-1380-1 SHORT COMMUNICATION Ethnic differences in the natural progression of nephropathy among diabetes patients in New Zealand: hospital admission
More informationNIH Public Access Author Manuscript Stroke. Author manuscript; available in PMC 2015 January 16.
NIH Public Access Author Manuscript Published in final edited form as: Stroke. 2013 November ; 44(11): 3229 3231. doi:10.1161/strokeaha.113.002814. Sex differences in the use of early do-not-resuscitate
More informationThis article shall be known, and may be cited as, the Newborn and Infant Hearing Screening, Tracking and Intervention Act.
CALIFORNIA CODES HEALTH AND SAFETY CODE SECTION 124115-124120.5 124115. This article shall be known, and may be cited as, the Newborn and Infant Hearing Screening, Tracking and Intervention Act. 124115.5.
More informationPROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC)
The Childhood Liver Disease Research Network strives to provide information and support to individuals and families affected by liver disease through its many research programs. PROGRESSIVE FAMILIAL INTRAHEPATIC
More informationIs surgical Apgar score an effective assessment tool for the prediction of postoperative complications in patients undergoing oesophagectomy?
Interactive CardioVascular and Thoracic Surgery 27 (2018) 686 691 doi:10.1093/icvts/ivy148 Advance Access publication 9 May 2018 BEST EVIDENCE TOPIC Cite this article as: Li S, Zhou K, Li P, Che G. Is
More informationResearch Article Fat-Soluble Vitamin Deficiency in Pediatric Patients with Biliary Atresia
Hindawi Gastroenterology Research and Practice Volume 2017, Article ID 7496860, 8 pages https://doi.org/10.1155/2017/7496860 Research Article Fat-Soluble Vitamin Deficiency in Pediatric Patients with Biliary
More informationClinical Improvement Following Home Parenteral Nutrition in Pediatric Patients with Intestinal Failure
ORIGINAL ARTICLE Clinical Improvement Following Home Parenteral Nutrition in Pediatric Patients with Intestinal Failure Yi-Ching Tung, Yen-Hsuan Ni, Hong-Shiee Lai, 1 Der-Yirng Hsieh, 2 Mei-Hwei Chang*
More informationDesign and Validation of the Biliary Atresia Research Consortium Histologic Assessment System for Cholestasis in Infancy
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:357 362 Design and Validation of the Biliary Atresia Research Consortium Histologic Assessment System for Cholestasis in Infancy PIERRE RUSSO,* JOHN C. MAGEE,
More informationResident, PGY1 David Geffen School of Medicine at UCLA. Los Angeles Society of Pathology Resident and Fellow Symposium 2013
Resident, PGY1 David Geffen School of Medicine at UCLA Los Angeles Society of Pathology Resident and Fellow Symposium 2013 85 year old female with past medical history including paroxysmal atrial fibrillation,
More informationBiliary atresia: clinical aspects
Seminars in Pediatric Surgery (2012) 21, 175-184 Biliary atresia: clinical aspects Mark Davenport, ChM, FRCS (Paeds) From the Department of Paediatric Surgery, King s College Hospital, Denmark Hill, London,
More informationFollow-up of pediatric chronic liver disease
IV CONVEGNO ITALO-BRASILIANO DI PEDIATRIA E NEONATOLOGIA SALVADOR DE BAHIA 21-23 MARZO 2006 Follow-up of pediatric chronic liver disease Antonio Colecchia, Luca Laudizi Dpt of Internal Medicine and Gastroenterology
More informationGreen Amber Red Assurance Level
A re-audit of the turnaround time of samples for the Sickle Cell and Thalassaemia Newborn Screening Programme, in the Manchester Newborn Screening Laboratory Clinical Audit Report May 2014 Clinical Audit
More informationTREATMENT OF PRIMARY BILIARY CIRRHOSIS (PBC)
TREATMENT OF PRIMARY BILIARY CIRRHOSIS (PBC) URSO not indicated Therapy for PBC Difficulties Etiology is uncertain Therapies are based on ideas regarding pathogenesis Present medical therapies have a limited
More information2. Description of the activity
Curricular Components for GI EPA 1. EPA Title Care of infants, children and adolescents with acute and chronic liver diseases, biliary/cholestatic diseases, pancreatic disorders, and those requiring liver
More informationOriginal Article Interfering effect of bilirubin on the determination of alkaline phosphatase
Int J Clin Exp Med 2014;7(11):4244-4248 www.ijcem.com /ISSN:1940-5901/IJCEM0002083 Original Article Interfering effect of bilirubin on the determination of alkaline phosphatase Zhong Wang, Hongyan Guo,
More informationCholestasis in the newborn: experience of a level III Neonatal Intensive Care Unit during 19 years
www.jpnim.com Open Access eissn: 2281-0692 Journal of Pediatric and Neonatal Individualized Medicine 2017;6(1):e060127 doi: 10.7363/060127 Received: 2016 Mar 16; revised: 2016 Jun 29; rerevised: 2016 Jul
More informationPrognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark
Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark Study of Prognosis of PSC Difficulties: Disease is rare The duration of the course of disease may be very
More informationLaparoscopic Cholecystectomy: A Retrospective Study
Bahrain Medical Bulletin, Vol. 37, No. 3, September 2015 Laparoscopic Cholecystectomy: A Retrospective Study Abdullah Al-Mitwalli, LRCPI, LRCSI* Martin Corbally, MBBCh, BAO, MCh, FRCSI, FRCSEd, FRCS**
More informationThe Healthcare Cost of Symptomatic Congenital CMV Disease in Privately Insured US Children: Estimates from Administrative Claims Data
National Center on Birth Defects and Developmental Disabilities The Healthcare Cost of Symptomatic Congenital CMV Disease in Privately Insured US Children: Estimates from Administrative Claims Data Scott
More informationDr. R. Pradheep. DNB Resident Pediatrics. Southern. Railway. Hospital.
Hyperbilirubinemia in an Infant Pradheep Railway Dr. R. DNB Resident Pediatrics. Southern Hospital. A 2 ½ month old male baby born out of 3 rd degree consanguinity presented to us with c/o yellow discolouration
More informationGuidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: ASPEN-SCCM 2017
Number of Patients Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: ASPEN-SCCM 2017 Jorge A. Coss-Bu, MD Associate Professor of Pediatrics
More informationRisk stratification in PBC
Risk stratification in PBC Christophe Corpechot Reference Center for Inflammatory Biliary Diseases Saint-Antoine hospital, Paris, France What is currently known (background) PBC : chronic, progressive
More informationInitiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator
Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator H Thom 1 BSc (Hons), Paediatric Diabetes Dietitian S Greene
More informationDOI: /peds The online version of this article, along with updated information and services, is located on the World Wide Web at:
Screening for Biliary Atresia by Infant Stool Color Card in Taiwan Shan-Ming Chen, Mei-Hwei Chang, Jung-Chieh Du, Chieh-Chung Lin, An-Chyi Chen, Hung-Chang Lee, Beng-Huat Lau, Yao-Jong Yang, Tzee-Chung
More informationDoes Bicarbonate Concentration Predict Hospitalization among Children with Gastroenteritis?
Does Bicarbonate Concentration Predict Hospitalization among Children with Gastroenteritis? Muin Habashneh MD*, Mohammad Alrwalah MD* ABSTRACT Objective: To determine the relationship between bicarbonate
More informationEnteral Nutrition in the Critically Ill Child: Challenges and Current Guidelines
Enteral Nutrition in the Critically Ill Child: Challenges and Current Guidelines 1 Presented on January 24, 2017 Jorge A. Coss-Bu, MD Associate Professor of Pediatrics Section of Critical Care Baylor College
More informationDiagnostics consultation document
National Institute for Health and Care Excellence Diagnostics consultation document Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive,
More informationOverall Goals and Objectives for Transplant Hepatology EPAs:
Overall Goals and Objectives for Transplant Hepatology EPAs: 1. DIAGNOSTIC LIST During the one-year Advanced Pediatric Transplant Hepatology Program, fellows are expected to develop comprehensive skills
More informationRisk Factors, Comorbid Conditions, and Epidemiology of Autism in Children
Award Number: W81XWH-12-2-0066 TITLE: Risk Factors, Comorbid Conditions, and Epidemiology of Autism in Children PRINCIPAL INVESTIGATOR: Major Cade Nylund, MC USAF CONTRACTING ORGANIZATION: Henry M Jackson
More informationEpstein-Barr Viral Load Before a Liver Transplant in Children With Chronic Liver Disease
ArtIcle Epstein-Barr Viral Load Before a Liver Transplant in Children With Chronic Liver Disease Nader Shakibazad, 1 Naser Honar, 1 Seyed Mohsen Dehghani, 2 Abdolvahab Alborzi 3 Abstract Objectives: Many
More informationPOSTOPERATIVE CONGENITAL ESOPHAGEAL ATRESIA COMPLICATIONS: A REVIEW
CHILDREN S HOSPITAL II POSTOPERATIVE CONGENITAL ESOPHAGEAL ATRESIA COMPLICATIONS: A REVIEW Dr. Nguyen Thuy Hanh Ngan Neonatal Department CONTENTS 1. Background 2. Classification 3. Management 4. Complications
More informationQuestion Sheet. Prospective Validation of the Pediatric Appendicitis Score in a Canadian Pediatric Emergency Department
Question Sheet Prospective Validation of the Pediatric Appendicitis Score in a Canadian Pediatric Emergency Department Bhatt M, Joseph L, Ducharme FM et al. Acad Emerg Med 2009;16(7):591-596 1. Provide
More informationCholedochal cyst in infancy and childhood Analysis of 16 cases
Archives of Disease in Childhood, 1977, 52, 121-128 Choledochal cyst in infancy and childhood Analysis of 16 cases AKIO KOBAYASH1 AND YOSHIRO OHBE From the Section of Gastroenterology, Department of Paediatrics,
More informationClostridium difficile Diagnostic and Clinical Challenges
Papers in Press. Published December 11, 2015 as doi:10.1373/clinchem.2015.243717 The latest version is at http://hwmaint.clinchem.org/cgi/doi/10.1373/clinchem.2015.243717 Clinical Chemistry 62:2 000 000
More informationWhat to Do when the Lights Don t Work- Neonatal Hyperbilirubinemia
What to Do when the Lights Don t Work- Neonatal Hyperbilirubinemia Dr G Elske Hildes-Ripstein Dept of Child Health and Pediatrics University of Manitoba, College of Medicine Annual Scientific Assembly;
More informationMap of Medicine National Library for Health
Map of Medicine National Library for Health Newborn hearing screening Check eligibility Eligible for screening Not eligible for screening Consider risk factors for hearing loss Provide information and
More informationHepatitis and pregnancy
Hepatitis and pregnancy Pierre-Jean Malè MD Training Course in Reproductive Health Research WHO Geneva 2008 26.02.2008 Liver disease and pregnancy: three possible etiologic relationship the patient has
More informationFish oil based lipid emulsion s role in transitioning pediatric patients from plant based to combination plant and fish oil based lipid emulsion
Fish oil based lipid emulsion s role in transitioning pediatric patients from plant based to combination plant and fish oil based lipid emulsion Kayley Liuzzo, PharmD PGY 1 Pharmacy Practice Resident Children
More informationInvestigation of Reports to VAERS of Death after Vaccination
Investigation of Reports to VAERS of Death after Vaccination Robert Ball, MD, MPH, ScM Chief, Vaccine Safety Branch Office of Biostatistics and Epidemiology for IOM Immunization Safety Review Committee
More informationReference Intervals for Intestinal Disaccharidase Activities Determined from a Non-Reference Population
Reference Intervals for Intestinal Disaccharidase Activities Determined from a Non-Reference Population Sarah A. Hackenmueller 1 and David G. Grenache 1,2 * Background: Cutoff activities for diagnosing
More informationPBC/AIH variant/ overlap syndrome vs PBC with hepatitic features?
22 November 2018 BD-IAP UK-LPG Liver Update PBC/AIH variant/ overlap syndrome vs PBC with hepatitic features? in a UDCA non-responder Dina G. Tiniakos Institute of Cellular Medicine, Faculty of Medical
More informationParacetamol Overdose Clinical Audit
The College of Emergency Medicine Clinical Audits Paracetamol Overdose Clinical Audit 2013-14 EXCELLENCE IN EMERGENCY MEDICINE Contents Executive Summary 3 Introduction 4 CEM Standards 4 Audit background
More informationCongenital Hypothyroidism Referral Guidelines for Newborn Bloodspot Screening Wales
Congenital Hypothyroidism Referral Guidelines for Newborn Bloodspot Screening Wales September 2014 Version 1 Based on the CHT initial Clinical Referral Standards and Guidelines in the UK [www.newbornbloodspot.screening.nhs.uk/cht]
More information